Ariti is pleased to announce its accession to the Your Pharma Partner in Europe (YPP) network, further strengthening its strategic presence in the European pharmaceutical sector and expanding its opportunities for developing new partnerships. Your Pharma Partner in Europe is…
LONDON – February [2], 2026 – Ayrmid, Ltd. (“Ayrmid” or the “Company”), the parent company of Gamida Cell Inc., today announced that it has entered into an exclusive distribution agreement with Ariti S.A., a Greece based pharmaceutical company for the distribution of…
Ariti S.A of Athens, Greece, announced today a strategic partnership with Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a global commercial-stage biopharmaceutical company focused on transforming the lives of patients living with rare neuroendocrine diseases. Through this collaboration, Ariti will spearhead multiple initiatives…